The newly created dedicated cycling unit as part of the International Testing Agency (ITA) is ready for operations from 1 January 2021. Since the decision by cycling’s governing body, the Union Cycliste Internationale (UCI), to transfer the responsibilities of the sport’s operational anti-doping activities from the Cycling Anti-Doping Foundation (CADF) to the ITA earlier this year, steady progress has been made to ensure a smooth transition and operational continuity.

To Riders and Support Personnel The 2021 Prohibited List comes into effect on 1 January 2021. It is highly recommended that all Riders and Support Staff take the time to familiarize themselves with this important information. (Several languages below)

In November 2019, following information and documents received from the Austrian law enforcement authorities as part of the Aderlass investigation [1], the Union Cycliste Internationale (UCI), cycling’s governing body, requested that the Cycling Anti-Doping Foundation (CADF) reanalyse samples taken during the 2016 and 2017 seasons. Based on further information received from law enforcement authorities and a comprehensive overall assessment, the CADF not only conducted the required reanalysis but also expanded the retesting to include samples as far back as 2013 and until 2019.

French version below The Cycling Anti-Doping Foundation (CADF) has completed the investigation it initiated in the aftermath of Remco Evenepoel’s crash at Il Lombardia on 15th August 2020 and the viewing of a video that showed a Team Deceuninck-Quick Step Sport Director removing an item from the rider’s pocket before placing it in his own pocket.

The Board of the Cycling Anti-Doping Foundation (CADF) announced today that its four individual members have decided to resign from their positions with immediate effect. The Board informed Un-ion Cycliste Internationale (UCI) Director General Amina Lanaya earlier today

On 27 May, the Cycling Anti-Doping Foundation (CADF) held its Funding Committee meeting in the presence of representatives from the Union Cycliste Internationale (UCI) and professional road cycling’s stakeholders – teams (AIGCP), riders (CPA) and organisers (AIOCC). On this occasion, it presented the effects of the coronavirus pandemic (Covid-19) on the anti-doping programme during March and April, and its plan to resume its activities with the return of cycling competitions for the 2020 season, as well as its 2019 business report.

Since the outbreak of COVID-19, declared a pandemic by the World Health Organisation (WHO) on 11 March, the impact of the coronavirus on society and sport has been considerable. Cycling is no exception, and this situation affects the activities of the entire cycling family worldwide. With respect to anti-doping activities, the Cycling Anti-Doping Foundation (CADF), the independent organisation in charge of the anti-doping strategy for cycling, is taking the situation very seriously. Together with the Union Cycliste Internationale (UCI) and the anti-doping community, the CADF is closely monitoring developments with the aim of continuing activities to protect clean cycling in the context of the coronavirus pandemic. Faced with this unprecedented situation, the CADF is adapting its anti-doping testing process and programme to remain in line with governmental measures and the guidance received from the World Anti-Doping Agency (WADA).

In response to growing media interest surrounding rider Jakob Fuglsang, Alexey Lutsenko and Dr Michele Ferrari, the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the Union Cycliste Internationale (UCI) to define and carry out anti-doping in the sport of cycling, would like to clarify a number of points.

01 February 2020 The Cycling Anti-Doping Foundation (CADF) has taken note of the decision by the Union Cycliste Internationale (UCI) to cease work with the CADF from 2021 onwards.